Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC)

Eval Program Plann. 2018 Jun:68:185-193. doi: 10.1016/j.evalprogplan.2018.03.004. Epub 2018 Mar 5.

Abstract

In collaboration with ministries of health, PATH and key partners launched the first pilot introductions of subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda from July 2014 through June 2016. While each country implemented a unique introduction strategy, all agreed to track a set of uniform indicators to chart the effect of introducing this new method across settings. Existing national health information systems (HIS) were unable to track new methods or delivery channels introduced for a pilot, thus were not a feasible source for project data. We successfully monitored the four-country pilot introductions by implementing a four-phase approach: 1) developing and defining global indicators, 2) integrating indicators into existing country data collection tools, 3) facilitating consistent reporting and data management, and 4) analyzing and interpreting data and sharing results. Project partners leveraged existing family planning registers to the extent possible, and introduced new or modified data collection and reporting tools to generate project-specific data where necessary. We routinely shared monitoring results with global and national stakeholders, informing decisions about future investments in the product and scale up of DMPA-SC nationwide. Our process and lessons learned may provide insights for countries planning to introduce DMPA-SC or other new contraceptive methods in settings where stakeholder expectations for measureable results for decision-making are high.

Keywords: Africa; Burkina Faso; Contraceptive introduction; DMPA-SC; Family planning; Health information systems (HIS); Indicators; Injectable contraception; Monitoring systems; Niger; Pilot; Product introduction; Sayana Press; Senegal; Subcutaneous DMPA; Uganda.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Africa South of the Sahara
  • Capacity Building
  • Contraceptive Agents, Female / administration & dosage*
  • Delayed-Action Preparations
  • Humans
  • Injections, Subcutaneous
  • Medroxyprogesterone Acetate / administration & dosage*
  • Pilot Projects
  • Program Development*
  • Program Evaluation / methods
  • Young Adult

Substances

  • Contraceptive Agents, Female
  • Delayed-Action Preparations
  • Medroxyprogesterone Acetate